ResearcherChinese PLA General HospitalNo recent work listed
Qu Liu
Matched on ORCID iD 0000-0002-5096-4911; OpenAlex author ID A5101894559. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers
Papers 6
- Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Co-author DOI 10.1002/cam4.5871↗
- Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center. Co-author DOI 10.1016/j.hbpd.2022.09.006↗
- Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hbpd.2022.09.009↗
- Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study. Co-author DOI 10.1007/s00423-021-02321-7↗
- Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.16573↗
- Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-… Co-author DOI 10.1016/j.ijsu.2018.05.024↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rong Liu · 5 shared papers, 2021–2023 · strength 0.81
- Paper Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term progn… DOI 10.1016/j.hbpd.2022.09.006↗
- Paper Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.hbpd.2022.09.009↗
- Paper Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. DOI 10.1002/cam4.5871↗
- Zhiming Zhao · 4 shared papers, 2021–2023 · strength 0.66
- Paper Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term progn… DOI 10.1016/j.hbpd.2022.09.006↗
- Paper Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.hbpd.2022.09.009↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Xiuping Zhang · 3 shared papers, 2022–2023 · strength 0.53
- Paper Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term progn… DOI 10.1016/j.hbpd.2022.09.006↗
- Paper Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.hbpd.2022.09.009↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Shuai Xu · 2 shared papers, 2023 · strength 0.39
- Paper Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term progn… DOI 10.1016/j.hbpd.2022.09.006↗
- Paper Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.hbpd.2022.09.009↗
- Minggen Hu · 2 shared papers, 2023 · strength 0.39
- Paper Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term progn… DOI 10.1016/j.hbpd.2022.09.006↗
- Paper Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. DOI 10.1016/j.hbpd.2022.09.009↗
- Wan Yee Lau · 2 shared papers, 2021–2022 · strength 0.27
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Paper Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of p… DOI 10.1111/jcmm.16573↗
- Wenbo Zou · 1 shared paper, 2023 · strength 0.19
- Shuang Si · 1 shared paper, 2023 · strength 0.15
- Zhuzeng Yin · 1 shared paper, 2023 · strength 0.15
- Zhiming Zhao · 1 shared paper, 2023 · strength 0.15
- Wei Li · 1 shared paper, 2023 · strength 0.15
- Quanli Han · 1 shared paper, 2023 · strength 0.15
- Shuai Xu · 1 shared paper, 2022 · strength 0.15
- Nan Jiang · 1 shared paper, 2022 · strength 0.15
- Guanghai Dai · 1 shared paper, 2022 · strength 0.15
- Xiu‐Ping Zhang · 1 shared paper, 2021 · strength 0.13
- Yuzhen Gao · 1 shared paper, 2021 · strength 0.13
- Lau Wan Yee · 1 shared paper, 2018 · strength 0.09
- Tan X · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.